You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 257 No. 4, January 23, 1987 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Clinical Investigation
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (93)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Decrease in Plasma High-Density Lipoprotein Cholesterol Levels at Puberty in Boys With Delayed Adolescence

Correlation With Plasma Testosterone Levels

Rebecca T. Kirkland, MD; Bruce S. Keenan, MD; Jeffrey L. Probstfield, MD; Wolfgang Patsch, MD; Tsai-Lien Lin, PhD; George W. Clayton, MD; William Insull, Jr, MD

JAMA. 1987;257(4):502-507.


Abstract

A three-phase study tested the hypothesis that the decrease in the high-density lipoprotein cholesterol (HDL-C) level observed in boys at puberty is related to an increase in the plasma testosterone concentration. In phase I,57 boys aged 10 to 17 years were categorized into four pubertal stages based on clinical parameters and plasma testosterone levels. These four groups showed increasing plasma testosterone values and decreasing HDL-C levels. In phase II, 14 boys with delayed adolescence were treated with testosterone enanthate (100, 200, and 200 mg/mo, respectively, for three months). Plasma testosterone levels during therapy were in the adult male range. Levels of HDL-C decreased by a mean of 7.4 mg/dL (0.20 mmol/L) and 13.7 mg/dL (0.35 mmol/L), respectively, after the first two doses. In phase III, 13 boys with delayed adolescence demonstrated increasing plasma testosterone levels and decreasing HDL-C levels ( —12.0 mg/dL [ — 0.30 mmol/L]) during spontaneous puberty. Levels of HDL-C and apolipoprotein A-1 were correlated during induced and spontaneous puberty. Testosterone should be considered a significant determinant (not necessarily directly causal) of plasma HDL-C levels during pubertal development.

(JAMA 1987;257:502-507)



Author Affiliations

From the Departments of Pediatrics (Drs Kirkland, Keenan, and Clayton) and Internal Medicine (Drs Probstfield, Patsch, Lin, and Insull), Baylor College of Medicine, Texas Children's Hospital, and The Methodist Hospital, Houston.


Footnotes

Presented in part at the 54th Scientific Session of the American Heart Association, Dallas, Nov 17,1981, and at the Sixth International Symposium on Atherosclerosis, Berlin, June 17,1982.

Reprint requests to the Department of Pediatrics, Baylor College of Medicine, One Baylor Plaza (Texas Medical Center), Houston, TX 77030 (Dr Kirkland).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Life-Course Origins of Social Inequalities in Metabolic Risk in the Population of a Developing Country
Schooling et al.
Am J Epidemiol 2008;167:419-428.
ABSTRACT | FULL TEXT  

Impact of Repeated Dietary Counseling Between Infancy and 14 Years of Age on Dietary Intakes and Serum Lipids and Lipoproteins: The STRIP Study
Niinikoski et al.
Circulation 2007;116:1032-1040.
ABSTRACT | FULL TEXT  

Monocyte proinflammatory cytokine release is higher and glucocorticoid sensitivity is lower in middle aged men than in women independent of cardiovascular risk factors
Wirtz et al.
Heart 2004;90:853-858.
ABSTRACT | FULL TEXT  

Negative relationships between growth in height and levels of cholesterol in puberty: a 3-year follow-up study
Kouda et al.
Int J Epidemiol 2003;32:1105-1110.
ABSTRACT | FULL TEXT  

Testosterone for secondary prevention in men with ischaemic heart disease?
Malkin et al.
QJM 2003;96:521-529.
FULL TEXT  

Androgens and Coronary Artery Disease
Wu and von Eckardstein
Endocr. Rev. 2003;24:183-217.
ABSTRACT | FULL TEXT  

Hormones, genetic factors, and gender differences in cardiovascular disease
Rossouw
Cardiovasc Res 2002;53:550-557.
FULL TEXT  

Dihydrotestosterone Treatment in Adolescents with Delayed Puberty: Does it Explain Insulin Resistance of Puberty?
Saad et al.
J. Clin. Endocrinol. Metab. 2001;86:4881-4886.
ABSTRACT | FULL TEXT  

Interrelationships among Lipoprotein Levels, Sex Hormones, Anthropometric Parameters, and Age in Hypogonadal Men Treated for 1 Year with a Permeation-Enhanced Testosterone Transdermal System
Dobs et al.
J. Clin. Endocrinol. Metab. 2001;86:1026-1033.
ABSTRACT | FULL TEXT  

Childhood Passive Smoking, Race, and Coronary Artery Disease Risk: The MCV Twin Study
Moskowitz et al.
Arch Pediatr Adolesc Med 1999;153:446-453.
ABSTRACT | FULL TEXT  

Prostate-Sparing Effects in Primates of the Potent Androgen 7{alpha}-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception
Cummings et al.
J. Clin. Endocrinol. Metab. 1998;83:4212-4219.
ABSTRACT | FULL TEXT  

Long-Term Prospective Study of Body Composition and Lipid Profiles during and after Growth Hormone (GH) Treatment in Children with GH Deficiency: Gender-Specific Metabolic Effects
Kuromaru et al.
J. Clin. Endocrinol. Metab. 1998;83:3890-3896.
ABSTRACT | FULL TEXT  

Testosterone Treatment in Adolescents with Delayed Puberty: Changes in Body Composition, Protein, Fat, and Glucose Metabolism
Arslanian and Suprasongsin
J. Clin. Endocrinol. Metab. 1997;82:3213-3220.
ABSTRACT | FULL TEXT  

Suppression of Endogenous Testosterone in Young Men Increases Serum Levels of High Density Lipoprotein Subclass Lipoprotein A-I and Lipoprotein(a)
von Eckardstein et al.
J. Clin. Endocrinol. Metab. 1997;82:3367-3372.
ABSTRACT | FULL TEXT  

Androgens in Men -- Uses and Abuses
Bagatell and Bremner
NEJM 1996;334:707-715.
FULL TEXT  

Effects of Androgens on Coronary Artery Atherosclerosis and Atherosclerosis-Related Impairment of Vascular Responsiveness
Adams et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:562-570.
ABSTRACT | FULL TEXT  

Lower Endogenous Androgen Levels and Dyslipidemia in Men with Non-Insulin-Dependent Diabetes Mellitus
Barrett-Connor
ANN INTERN MED 1992;117:807-811.
ABSTRACT  

Physiologic Testosterone Levels in Normal Men Suppress High-Density Lipoprotein Cholesterol Levels
Bagatell et al.
ANN INTERN MED 1992;116:967-973.
ABSTRACT  

The Relationship Between Sex Hormones and High-Density Lipoprotein Cholesterol Levels in Healthy Adult Men
Duell and Bierman
Arch Intern Med 1990;150:2317-2320.
ABSTRACT  

Testosterone Replacement With Transdermal Therapeutic Systems: Physiological Serum Testosterone and Elevated Dihydrotestosterone Levels
Cunningham et al.
JAMA 1989;261:2525-2530.
ABSTRACT  

Low-Level Cigarette Smoking and Longitudinal Change in Serum Cholesterol Among Adolescents: The Berlin-Bremen Study
Dwyer et al.
JAMA 1988;259:2857-2862.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.